Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer
Viruses · 2023
DOI: 10.3390/v15040901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Tatyana Gavrikova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Gene Therapy, Department of Surgery, Medicine and Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Adenoviridae, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, DOD PCRP DAMD17-03-1-0104.
Abstract (Originalsprache)
Background
The development of conditionally replicative adenoviruses (CRAds) for castration-resistant prostate cancer (CRPC), particularly neuroendocrine prostate cancer (NEPC), has two major obstacles: choice of control element and poor infectivity. We applied fiber-modification-based infectivity enhancement and an androgen-independent promoter (cyclooxynegase-2, COX-2) to overcome these issues.
Methods
The properties of the COX-2 promoter and the effect of fiber modification were tested in two CRPC cell lines (Du-145 and PC3). Fiber-modified COX-2 CRAds were tested in vitro for cytocidal effect as well as in vivo for antitumor effect with subcutaneous CRPC xenografts.
Results
In both CRPC cell lines, the COX-2 promoter showed high activity, and Ad5/Ad3 fiber modification significantly enhanced adenoviral infectivity. COX-2 CRAds showed a potent cytocidal effect in CRPC cells with remarkable augmentation by fiber modification. In vivo, COX-2 CRAds showed an antitumor effect in Du-145 while only Ad5/Ad3 CRAd showed the strongest antitumor effect in PC3.
Conclusion
COX-2 promoter–based, infectivity-enhanced CRAds showed a potent antitumor effect in CRPC/NEPC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Gene Therapy, Department of Surgery, Medicine and Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA.
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
- Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
ORCID-Profile: Naohiko Nakamura
Förderung
- NCI NIH HHS
- NIH HHS
- DOD PCRP DAMD17-03-1-0104
- NIH/NCI R01CA228760
- NIH/NCI R01CA276480
Zitieren
APA
Gavrikova, T., Nakamura, N., Davydova, J., Antonarakis, E. S., & Yamamoto, M. (2023). Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer. Viruses. https://doi.org/10.3390/v15040901
Vancouver
Gavrikova T, Nakamura N, Davydova J, Antonarakis ES, Yamamoto M. Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer. Viruses. 2023. doi:10.3390/v15040901
BibTeX
@article{Gavrikova2023,
author = {Gavrikova, Tatyana and Nakamura, Naohiko and Davydova, Julia and Antonarakis, Emmanuel S and Yamamoto, Masato},
title = {Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040901}
}
EUVIMED